标题
Discovery methods of coagulation-inhibiting drugs
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 12, Issue 12, Pages 1195-1205
出版商
Informa UK Limited
发表日期
2017-09-27
DOI
10.1080/17460441.2017.1384811
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation
- (2017) Cynthia A Jackevicius et al. HEART
- Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker
- (2017) James R. Corte et al. JOURNAL OF MEDICINAL CHEMISTRY
- A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release
- (2017) K.-A. Steen Burrell et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inorganic polyphosphate: a key modulator of inflammation
- (2017) S. M. Hassanian et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel antiplatelet role for a protein disulfide isomerase-targeted peptide: evidence of covalent binding to the C-terminal CGHC redox motif
- (2017) H. R. Sousa et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A new antithrombotic strategy: inhibition of the C-terminal active site of protein disulfide isomerase
- (2017) L. Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review
- (2017) Sung M. Cho et al. Neurocritical Care
- Laboratory Assessment of Direct Oral Anticoagulants
- (2017) Robert Gosselin et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Generation and characterization of aptamers targeting factor XIa
- (2017) R.S. Woodruff et al. THROMBOSIS RESEARCH
- Inhibition of Protein Disulfide Isomerase in Thrombosis
- (2016) Roelof H. Bekendam et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events
- (2016) Meir Preis et al. BLOOD
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPACE
- Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study
- (2016) P. Gueret et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The discovery of dabigatran etexilate for the treatment of venous thrombosis
- (2016) Martin Feuring et al. Expert Opinion on Drug Discovery
- Factor XIa inhibitors: A review of the patent literature
- (2016) Rami A. Al-Horani et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy
- (2016) Allison P. Wheeler et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
- (2016) Thomas J. Povsic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Trends in the Management and Outcomes of Acute Pulmonary Embolism
- (2016) David Jiménez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis
- (2016) C. Zhong et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
- (2016) A Michael Lincoff et al. LANCET
- Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI
- (2016) Cristina Puy et al. PLoS One
- Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile
- (2016) Rami A. Al-Horani et al. PLoS One
- Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant
- (2016) Erin E. Soule et al. Nucleic Acid Therapeutics
- Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- P-Selectin Inhibition Therapeutically Promotes Thrombus Resolution and Prevents Vein Wall Fibrosis Better Than Enoxaparin and an Inhibitor to von Willebrand FactorSignificance
- (2015) Jose A. Diaz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Modulation of the Coagulation Cascade Using AptamersSignificance
- (2015) Rebecca S. Woodruff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Development of a novel class of potent and selective FIXa inhibitors
- (2015) Ting Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives
- (2015) Antonio Gómez-Outes et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Factor XI and contact activation as targets for antithrombotic therapy
- (2015) D. Gailani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Discovery and characterization of an antibody directed against exosite I of thrombin
- (2015) T. P. Baglin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa
- (2015) Pancras C. Wong et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
- (2015) Harry R. Büller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laboratory Testing in the Era of Direct or Non–Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to Measuring Their Activity and Avoiding Diagnostic Errors
- (2015) Giuseppe Lippi et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants
- (2015) Rami A. Al-Horani et al. THROMBOSIS RESEARCH
- Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
- (2014) Paul L. Hess et al. AMERICAN HEART JOURNAL
- Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis
- (2014) R. J. Travers et al. BLOOD
- Stroke in Dialysis and Chronic Kidney Disease
- (2014) Albert Power BLOOD PURIFICATION
- Allosteric Inhibition of Human Factor XIa: Discovery of Monosulfated Benzofurans as a Class of Promising Inhibitors
- (2014) Malaika D. Argade et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity
- (2014) W. Chen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
- (2014) Gergana Galabova et al. PLoS One
- Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants
- (2014) R. A. Shenoi et al. Science Translational Medicine
- Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venom
- (2014) Tse Siang Kang et al. THROMBOSIS AND HAEMOSTASIS
- Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians
- (2013) Amir Qaseem ANNALS OF INTERNAL MEDICINE
- Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
- (2013) Rajiv Chowdhury et al. EUROPEAN HEART JOURNAL
- Designing Allosteric Regulators of Thrombin. Exosite 2 Features Multiple Subsites That Can Be Targeted by Sulfated Small Molecules for Inducing Inhibition
- (2013) Preetpal Singh Sidhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer
- (2013) R. S. Woodruff et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement
- (2013) Sophie Gunn et al. THROMBOSIS AND HAEMOSTASIS
- Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model
- (2013) Maurits L. van Montfoort et al. THROMBOSIS AND HAEMOSTASIS
- Active immunotherapy for chronic diseases
- (2013) Martin F. Bachmann et al. VACCINE
- The discovery of rivaroxaban: translating preclinical assessments into clinical practice
- (2013) Dagmar Kubitza et al. Frontiers in Pharmacology
- Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
- (2012) H. S. Younis et al. BLOOD
- Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation
- (2012) S. A. Smith et al. BLOOD
- Prevention of VTE in Orthopedic Surgery Patients
- (2012) Yngve Falck-Ytter et al. CHEST
- Prevention of VTE in Nonorthopedic Surgical Patients
- (2012) Michael K. Gould et al. CHEST
- A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity
- (2012) K. M. BOMPIANI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice
- (2012) Philberta Y. Leung et al. Translational Stroke Research
- Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
- (2011) A. S. Revenko et al. BLOOD
- Aptamer-based modulation of blood coagulation
- (2011) G. Mayer et al. Hamostaseologie
- Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial
- (2011) P. VERHAMME et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
- (2011) Pancras C. Wong et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
- (2010) Q. Cheng et al. BLOOD
- Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
- (2010) H. Zhang et al. BLOOD
- Tolerability and pharmacokinetics of TB-402 in healthy male volunteers
- (2010) Peter Verhamme et al. CLINICAL THERAPEUTICS
- Nucleic acid aptamers as antithrombotic agents: Opportunities in extracellular therapeutics
- (2010) Thomas Povsic et al. THROMBOSIS AND HAEMOSTASIS
- An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase
- (2009) Sai K. Buddai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
- (2008) E. I. Tucker et al. BLOOD
- Platelet inorganic polyphosphate decreases in patients with delta storage pool disease
- (2008) L. HERNÁNDEZ-RUIZ et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation